Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 New Anti-Aging Company Targets Gut-Body Axis, Seeks Investors - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

New Anti-Aging Company Targets Gut-Body Axis, Seeks Investors

Research centers on molecules that bind to specific docking sites in the gut that, when activated, determine how immune cells behave.

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

A new anti-aging company called Propion, AKA How to Slow Time, Inc, is developing technology to improve health by targeting the immune system through the gut microbiome.
 
Daniel Winer, MD, the company’s founder, is a microbiome researcher with professorship positions at three universities: The Buck Institute for Research on Aging, the University of Toronto, and the University of Southern California.
 
His work in gastro immunology, or the gastrointestinal and immune system, has received numerous awards. He is also a pioneer in the field of astroimmunology, collaborating with NASA and SpaceX to understand how immune cells may act differently in space. His co-founder, Nicholas Tubach, hails from UC Berkeley.
 
Their research centers on molecules that bind to specific docking sites in the gut. When activated, these sites determine how immune cells behave. By encouraging reparative immune cell activity, the molecules could have a regenerative effect on the microbiome, the company said.
 
“The immune system in the GI tract becomes increasingly dysfunctional as you age,” Winer noted. “This plays a big role in the deterioration of your body since the gut signals to every organ.”
 
Several degenerative conditions have been linked to a deficiency in the human body’s production of the molecules, which the company has called “Propion 1” and “Propion 2.”
“With these completely new molecules, we could correct signaling imbalance, one effect of which could be to reduce leaky gut caused by aging and the modern diet,” Winer said. “That would boost not only gastrointestinal health but also brain, liver, heart, and skin health.”
 
Currently, the company is manufacturing prototypes for its first product, Propion Blend, which according to its website “is a proprietary combination of amino acids, superfoods, and proteins.”
 
“We started the company because we want to take the products we’re developing ourselves,” Tubach said. “I would say the rate-limiting factor on our ability to bring our technology to market is the funding environment for startups right now.”
 
Propion is seeking investment from angel investors and venture capital groups.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics